US equities
|
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
MU
$877.55
▲+2.46%
NVDA
$210.96
▼-0.59%
SPCX
$147.49
▲+1.89%
AAPL
$347.73
▼-0.14%
TSLA
$372.22
▼-0.63%
SNDK
$1,238.03
▼-1.82%
META
$642.62
▼-0.96%
AMD
$516.79
▲+1.74%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Articles published by Medicure, Inc.
Medicure Announces Grant of Stock Options
October 01, 2026
From
Medicure, Inc.
Via
ACCESS Newswire
Tickers
MCUJF
TSX-V:MPH
Medicure Announces Completion of Enrollment in Its MEND-PNPO Phase 3 Clinical Trial
September 28, 2026
From
Medicure, Inc.
Via
ACCESS Newswire
Tickers
MCUJF
TSX-V:MPH
Medicure Presents MEND-PNPO Phase 3 Study Design and Baseline Data at the 16th European Epilepsy Congress
September 08, 2026
From
Medicure, Inc.
Via
ACCESS Newswire
Tickers
MCUJF
TSX-V:MPH
Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
August 14, 2026
From
Medicure, Inc.
Via
ACCESS Newswire
Tickers
MCUJF
TSX-V:MPH
Medicure Announces CFO Change
July 03, 2026
From
Medicure, Inc.
Via
ACCESS Newswire
Tickers
MCUJF
TSX-V:MPH